Morgan Stanley
BDSX icon

Morgan Stanley’s Biodesix BDSX Stock Holding History

Morgan Stanley’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38K Sell
61
-32,331
-100% -$479K ﹤0.01% 7467
2026
Q1 		$470K Buy
32,392
+32,331
+53,002% +$401K ﹤0.01% 5518
2025
Q4 		$415 Sell
61
-15
-20% -$110 ﹤0.01% 7534
2025
Q3 		$574 Buy
76
+12
+19% +$92 ﹤0.01% 7477
2025
Q2 		$361 Sell
64
-580
-90% -$4.68K ﹤0.01% 7495
2025
Q1 		$8.05K Sell
644
-1,370
-68% -$26.3K ﹤0.01% 6868
2024
Q4 		$61.6K Buy
2,014
+1,642
+441% +$48.3K ﹤0.01% 6227
2024
Q3 		$13.2K Hold
372
– – ﹤0.01% 6635
2024
Q2 		$11.4K Sell
372
-87
-19% -$2.48K ﹤0.01% 6631
2024
Q1 		$13.1K Sell
459
-48
-9% -$1.64K ﹤0.01% 6602
2023
Q4 		$18.6K Sell
507
-27
-5% -$848 ﹤0.01% 6465
2023
Q3 		$17.6K Sell
534
-422
-44% -$11.7K ﹤0.01% 6526
2023
Q2 		$23.5K Sell
956
-1,604
-63% -$48.1K ﹤0.01% 6515
2023
Q1 		$95.2K Sell
2,560
-50
-2% -$2.05K ﹤0.01% 6020
2022
Q4 		$120K Sell
2,610
-238
-8% -$6.47K ﹤0.01% 5897
2022
Q3 		$71K Sell
2,848
-846
-23% -$32.6K ﹤0.01% 6240
2022
Q2 		$122K Buy
3,694
+901
+32% +$29.3K ﹤0.01% 6168
2022
Q1 		$94K Sell
2,793
-472
-14% -$30.8K ﹤0.01% 6348
2021
Q4 		$345K Sell
3,265
-2,161
-40% -$282K ﹤0.01% 5767
2021
Q3 		$892K Buy
5,426
+3,246
+149% +$616K ﹤0.01% 5125
2021
Q2 		$575K Buy
2,180
+1,709
+363% +$537K ﹤0.01% 5442
2021
Q1 		$191K Sell
471
-1,321
-74% -$590K ﹤0.01% 5683
2020
Q4 		$722K Buy
+1,792
New +$558K ﹤0.01% 4849

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Morgan Stanley's BDSX Position: Q2 2026 in Review

Morgan Stanley reduced its Biodesix (BDSX) stake by 100% in Q2 2026, selling an estimated $479K and leaving 61 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #7467.

Morgan Stanley first reported a position in BDSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $892K in Q3 2021. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Morgan Stanley held 61 shares of Biodesix worth $1.38K as of Q2 2026.
  • Morgan Stanley sold 32,331 Biodesix shares in Q2 2026, an estimated $479K.
  • Biodesix made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7467 holding.
  • Morgan Stanley first reported a position in Biodesix in Q4 2020 and has held it in 23 quarters since.
  • Morgan Stanley's Biodesix position peaked at $892K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.